Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer symbols : PPRUF save search
US FDA grants Orphan Drug Designation for iOnctura's first-in-class autotaxin cancer therapy
Published: 2024-03-07 (Crawled : 08:00) - prnewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -1.57%
H: 1.91%
C: 0.49%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -0.6%
H: 1.23%
C: 1.17%
fda drug cancer designation grants therapy
Osara Health announces partnership with Allstate Benefits to offer members cancer care support - a first in the US health insurance market
Published: 2024-03-05 (Crawled : 13:00) - prnewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 0.97%
H: 0.0%
C: -3.25%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -1.81%
H: 0.77%
C: 0.54%
partnership first health cancer care insurance benefits market
New research highlights potential of iOnctura strategy combining autotaxin and TGF-β inhibitors in cancer
Published: 2023-10-19 (Crawled : 08:00) - prnewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.57%
H: 1.09%
C: 0.98%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 1.4%
H: 0.53%
C: -0.81%
cancer research potential
iOnctura awarded EUR17.5 million funding from the EIC Accelerator for clinical development of novel pancreatic cancer therapy
Published: 2022-12-20 (Crawled : 11:00) - prnewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -4.78%
H: 5.74%
C: 3.12%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -3.2%
H: 0.54%
C: 0.16%
eur17 funding therapy cancer pancreatic
iOnctura initiates Phase Ib pancreatic cancer trial of next-generation autotaxin inhibitor IOA-289
Published: 2022-12-08 (Crawled : 10:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 3.56%
H: 1.16%
C: -1.27%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -0.11%
H: 0.71%
C: 0.24%
ioa-289 trial cancer pancreatic
InterVenn to Present New Clinical Data at ASCO 2022 on Using Glycoproteomics as Powerful Liquid Biopsy Tests for Early Detection of Cancer and Prediction of Checkpoint Inhibitor Treatment Benefit
Published: 2022-05-06 (Crawled : 19:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.99%
H: 2.35%
C: -1.24%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -2.72%
H: 1.32%
C: -0.12%
treatment asco cancer
Reimagine Care Secures $25 Million in Series A Funding to Drive Commercialization of Home-Centered, Value-Based Cancer Care
Published: 2022-01-25 (Crawled : 15:30) - biospace.com/
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -3.6%
H: 4.1%
C: 0.68%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -1.24%
H: 0.52%
C: -0.11%
commercialization funding cancer
iOnctura Presents Positive Clinical Data At ESMO-IO Supporting Advancement of IOA-289, a Novel Autotaxin Inhibitor, Into Phase Ib Pancreatic Cancer Studies
Published: 2021-12-09 (Crawled : 08:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -6.26%
H: 4.62%
C: 0.72%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -2.24%
H: 0.01%
C: -0.69%
ioa-289 xin positive cancer pancreatic
Carlos Ponce, Tania Medina, Karina Banda, Ingrid Macher And Pablo García Close The Breast Cancer Awareness Campaign In Times Square
Published: 2021-10-22 (Crawled : 18:00) - prnewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 0.08%
H: 0.19%
C: 0.19%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 0.44%
H: 0.01%
C: -0.08%
cancer breast cancer
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.